Discover
AGMB
AgomAb Therapeutics NV
11.87
2 x 9.34
2 x 15.29
bid
ask
-
1.11
8.55%
2 @ 04:00 PM
12.03 +0.16 (1.35%)
| Ytd | -18.98% | |
| 1y | -18.98% |
11.53
day range
13.25
8.75
52 week range
17.82
| Open | 12.98 | Prev Close | 12.98 | Low | 11.53 | High | 13.25 | Mkt Cap | 584.57M |
| Vol | 166.65K | Avg Vol | 125.26K | EPS | -1.46 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 11.39 | 200-d Avg | 12.34 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 16.53M | ||
| Research and Development Expense | 13.86M | ||
| Selling, General and Administrative Expense | 3.17M | ||
| Operating Income | -16.53M | ||
| Interest Expense | -66.00K | ||
| Net Income | -17.40M | ||
| Net Income Common Stock | -17.40M | ||
| Net Income Common Stock (USD) | -20.47M | ||
| Consolidated Income | -17.40M | ||
| Earnings per Basic Share | -140.96 | ||
| Earnings per Basic Share (USD) | -165.83 | ||
| Earnings per Diluted Share | -140.96 | ||
| Earning Before Interest & Taxes (EBIT) | -17.47M | ||
| Earning Before Interest & Taxes (USD) | -20.55M | ||
| Weighted Average Shares | 541.13K | ||
| Weighted Average Shares Diluted | 541.13K | ||
| Balance Sheet | |||
| Cash and Equivalents | 86.42M | ||
| Cash and Equivalents (USD) | 101.67M | ||
| Investments | 30.11M | ||
| Investments Current | 30.10M | ||
| Investments Non-Current | 11.00K | ||
| Current Assets | 121.24M | ||
| Property, Plant & Equipment Net | 1.59M | ||
| Total Assets | 153.71M | ||
| Debt Current | 249.00K | ||
| Total Debt | 1.25M | ||
| Current Liabilities | 18.59M | ||
| Debt Non-Current | 1.00M | ||
| Total Liabilities | 22.80M | ||
| Accumulated Retained Earnings (Deficit) | -181.71M | ||
| Shareholders Equity | 130.90M | ||
| Shareholders Equity (USD) | 154.00M | ||
| Assets Non-Current | 32.47M | ||
| Total Debt (USD) | 1.48M | ||
| Deferred Revenue | 1.55M | ||
| Goodwill and Intangible Assets | 28.72M | ||
| Liabilities Non-Current | 4.22M | ||
| Trade and Non-Trade Payables | 10.27M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -83.00K | ||
| Net Cash Flow from Financing | -34.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -43.21M | ||
| Capital Expenditure | -4.00K | ||
| Issuance (Repayment) of Debt Securities | -34.00K | ||
| Net Cash Flow from Investing | -30.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -30.00M | ||
| Net Cash Flow from Operations | -13.17M | ||
| Share Based Compensation | 1.42M | ||